Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism
about
Evaluation of an Unfractionated Heparin Pharmacy Dosing Protocol for the Treatment of Venous Thromboembolism in Nonobese, Obese, and Severely Obese Patients.The safety of fondaparinux sodium for the treatment of venous thromboembolism.Evaluation of safety and effectiveness of standardized antifactor Xa-based unfractionated heparin protocols in obese versus non-obese patients.Considerations for analgosedation and antithrombotic management during extracorporeal life support.The danger of relying on the APTT and PT in patients on DOAC therapy, a potential patient safety issue.Assessment of venous thromboembolism treatment in patients with cancer on low molecular weight heparin, warfarin, and the direct oral anticoagulants.Synthetic oligosaccharides can replace animal-sourced low-molecular weight heparins.Appropriateness of direct oral anticoagulant dosing for venous thromboembolism treatment.Can we reliably predict the level of anticoagulation after enoxaparin injection in elderly patients with renal failure?Effects of Chitosan Derivative N-[(2-Hydroxy-3-Trimethylammonium)Propyl]Chloride on Anticoagulant Activity of Guinea Pig Plasma.Accuracy, reproducibility and costs of different laboratory assays for the monitoring of unfractionated heparin in clinical practice: a prospective evaluation study and survey among Swiss institutions.
P2860
Q38782259-57247F80-436F-4DFB-85A2-ACBBA1D7485DQ38930816-4F8778B5-2390-4070-823A-3EEB14ADC441Q39030017-E81EFF70-E0A1-4FDE-9E3A-2502B565818EQ39169651-310F08B4-F417-463E-B822-1BB6B0753EB0Q39266324-95943838-E39A-46E5-9C9B-3944FDE39BF8Q47186286-EB65EC89-EB4B-4452-B8FE-EBCBB7C7C9A4Q47189835-BEB769D2-52BD-4BF7-9D28-55E50BBD1987Q48152210-8D8B4309-67C0-43E2-865B-B317FC5167D5Q48238213-546159DD-611F-4752-B1A7-8DCBC1FAC835Q50519804-B988FA89-E936-4E59-BEC2-E5C1F42EB9ADQ55337905-1B4150B5-D78B-4A96-9669-DF687FD4C6E8
P2860
Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Guidance for the practical man ...... ment of venous thromboembolism
@ast
Guidance for the practical man ...... ment of venous thromboembolism
@en
Guidance for the practical man ...... ment of venous thromboembolism
@nl
type
label
Guidance for the practical man ...... ment of venous thromboembolism
@ast
Guidance for the practical man ...... ment of venous thromboembolism
@en
Guidance for the practical man ...... ment of venous thromboembolism
@nl
prefLabel
Guidance for the practical man ...... ment of venous thromboembolism
@ast
Guidance for the practical man ...... ment of venous thromboembolism
@en
Guidance for the practical man ...... ment of venous thromboembolism
@nl
P2093
P2860
P921
P1476
Guidance for the practical man ...... ment of venous thromboembolism
@en
P2093
Adam Cuker
Ann K. Wittkowsky
Diane Wirth
Jennifer Priziola
Maureen A. Smythe
Paul P. Dobesh
P2860
P2888
P304
P356
10.1007/S11239-015-1315-2
P407
P5008
P577
2016-01-01T00:00:00Z